Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BNTC stock hub

Benitec Biopharma Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BNTCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
420.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
BNTC
In the news

Latest news · BNTC

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-33.5
P25 -105.6P50 -46.5P75 -3.1
ROIC-22.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BNTC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
179
Groups with data
11
Currency
USD
Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001552795
Company name
Benitec Biopharma Inc.
Country
United States
Country code
US
Cusip
08205P100
Employees
19
Employees Change
3%
Employees Change Percent
18.75
Enterprise value
$232.8M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
US08205P2092
Last refreshed
2026-05-10
Market cap
$420.7M
Market cap category
Small-Cap
Price
$12.28
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
BNTC
Website
https://benitec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-10.49%
FCF yield
-4.38%
P/B ratio
2.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-44.1M
Net Income Growth Years
0%
Profit Per Employee
$-2.3M
ROA
-22.4
Roa5y
-89.13
ROCE
-25.73
ROE
-33.5
Roe5y
-332.7
ROIC
-22.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr10y
-30.14%
Cagr1y
-9.31%
Cagr3y
46.65%
Cagr5y
-29.75%
EPS Growth Years
5
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Assets
$190.7M
Cash
$188.8M
Current Assets
$189.6M
Current Liabilities
$2.8M
Debt
$987,000
Debt Equity
$0.01
Equity
$187.4M
Liabilities
$3.3M
Long Term Assets
$1.1M
Long Term Liabilities
$519,000
Net Cash
$187.8M
Net Cash By Market Cap
$44.65
Net Cash Growth
140.32%
Net Debt Equity
$-1
Tangible Book Value
$187.4M
Tangible Book Value Per Share
$5.47
WACC
5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
67.69
Net Working Capital
$-1.5M
Quick ratio
67.45
Working Capital
$186.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-24.88%
Dividend per share
$0
Dividend Yield
0%
Last Dividend
$0.7

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-97.23%
1Y total return
-9.31%
200-day SMA
12.7
3Y total return
215.44%
50-day SMA
11.79
50-day SMA vs 200-day SMA
50under200
5Y total return
-82.88%
All Time High
5,916
All Time High Change
-99.79%
All Time High Date
2014-07-07
All Time Low
1.86
All Time Low Change
560.22%
All Time Low Date
2023-08-09
ATR
0.71
Beta
0.28
Beta1y
1.43
Beta2y
0.89
Ch YTD
-8.83
High
12.7
High52
17.15
High52 Date
2025-06-10
High52ch
-28.4%
Low
11.82
Low52
9.85
Low52 Date
2026-02-17
Low52ch
24.67%
Ma50ch
4.14%
Price vs 200-day SMA
-3.31%
RSI
51.06
RSI Monthly
45.96
RSI Weekly
50.44
Sharpe ratio
0.09x
Sortino ratio
0.21
Total Return
-24.88%
Tr YTD
-8.83
Tr1m
12.56%
Tr1w
2.76%
Tr3m
1.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

10
MetricValue
Analyst Count
3
Analyst Count Top
2
Analyst Price Target Top
$25.5
Analyst Ratings
Strong Buy
Analyst Ratings Top
Buy
Earnings EPS Estimate
$-0.27
Operating Income
$-48.3M
Price target
$27.67
Price Target Change
$125
Price Target Change Top
$108

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
17,773,778%
Float Percent
51.89%
Shares Insiders
2.81%
Shares Institutions
51.77%
Shares Out
34,254,907
Shares Qo Q
10.72%
Shares Yo Y
24.88%
Short Float
12.75%
Short Ratio
16.08
Short Shares
6.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
$-44.9M
Average Volume
114,780.1x
Bv Per Share
5.47
CAPEX
$-17,000
Ch10y
-97.23
Ch1m
12.56
Ch1w
2.76
Ch1y
-9.31
Ch3m
1.32
Ch3y
215.4
Ch5y
-82.88
Ch6m
-3.99
Change
1.15%
Change From Open
1.91
Close
12.14
Days Gap
-0.74
Depreciation Amortization
54,000
Dollar Volume
2,078,218.1
Earnings Date
2026-05-14
Earnings Time
bmo
EBIT
$-48.3M
EBITDA
$-48.3M
EPS
$-1.06
F Score
2
FCF
$-18.4M
FCF EV Yield
-7.92x
FCF Per Share
$-0.54
Financing CF
129,188,000
Fiscal Year End
June
Founded
1,995
Investing CF
-17,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Last Split Date
2023-07-26
Last Split Type
Reverse
Last10k Filing Date
2019-10-30
Ma150
12.63
Ma150ch
-2.79%
Ma20
12.7
Ma20ch
-3.27%
Net CF
110,558,000
Next Earnings Date
2026-05-22
Open
12.05
Optionable
Yes
Position In Range
52.27
Ppne
1,020,000
Price Date
2026-05-08
Ptbv Ratio
2.25
Relative Volume
1.47x
Share Based Comp
26,412,000
Tr6m
-3.99%
Us State
California
Volume
169,236
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BNTC pay a dividend?

Capital-return profile for this ticker.

Performance

BNTC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-9.3%
S&P 500 1Y: n/a
3Y total return
+215.4%
S&P 500 3Y: n/a
5Y total return
-82.9%
S&P 500 5Y: n/a
10Y total return
-97.2%
S&P 500 10Y: n/a
Ownership

Who owns BNTC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+51.8%
Float: +51.9% of shares outstanding
Insider ownership
+2.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+12.8%
16.1 days to cover
Y/Y dilution
+24.9%
Negative means the company is buying back shares.
Technical

BNTC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.1
Neutral momentum band
Price vs 200-day MA
-3.3%
50/200-day relationship not available
Beta (5Y)
0.28
Less volatile than the market
Sharpe ratio
0.09
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BNTC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BNTC stock rating?

Benitec Biopharma Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BNTC analysis?

The full report lives at /stocks/BNTC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BNTC?

The latest report frames BNTC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BNTC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.